An Update of Anticoagulant Strategies in Noncritically Ill Patients Hospitalized with COVID-19.
作者信息
Iranian Mohammadreza, Rostamkolaei Seyed Shahab
机构信息
Iran University of Medical Sciences, School of Medicine, Rajaie Cardiovascular Medical and Research Center, Vali-e-Asr Street, Tehran, Iran. 1995614331. Tell: +98 21 23921. Fax: +98 21 22042026. E-mail:
出版信息
J Tehran Heart Cent. 2024 Apr;19(2):151-152. doi: 10.18502/jthc.v19i2.16208.
Abstract
摘要
相似文献
1
An Update of Anticoagulant Strategies in Noncritically Ill Patients Hospitalized with COVID-19.COVID-19住院非危重症患者抗凝策略的最新进展
J Tehran Heart Cent. 2024 Apr;19(2):151-152. doi: 10.18502/jthc.v19i2.16208.
2
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19.COVID-19 住院非危重症患者抗凝策略的随机试验。
J Am Coll Cardiol. 2023 May 9;81(18):1747-1762. doi: 10.1016/j.jacc.2023.02.041. Epub 2023 Mar 6.
3
Venous Thromboembolism among Noncritically Ill Hospitalized Children: Key Considerations for the Pediatric Hospital Medicine Specialist.非危重症住院患儿中的静脉血栓栓塞症：儿科医院医学专家的关键考虑因素。
Semin Thromb Hemost. 2022 Jun;48(4):434-445. doi: 10.1055/s-0041-1729170. Epub 2021 May 7.
4
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.危重症 COVID-19 患者单核细胞 HLA-DR 表达降低提示免疫抑制。
Anesth Analg. 2020 Oct;131(4):993-999. doi: 10.1213/ANE.0000000000005044.
5
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years.新冠疫情两年后的经验教训：新冠患者是否需要抗凝治疗
Semin Thromb Hemost. 2023 Feb;49(1):62-72. doi: 10.1055/s-0042-1744302. Epub 2022 Apr 25.
6
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.治疗剂量肝素对因COVID-19住院的非危重症患者严重急性肾损伤和死亡的影响：ACTIV4a和ATTACC随机试验的预先设定的二次分析
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102167. doi: 10.1016/j.rpth.2023.102167. eCollection 2023 Aug.
7
Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia.沙特阿拉伯一家三级医院非危重症住院儿童使用质子泵抑制剂的合理性。
Saudi Pharm J. 2023 Sep;31(9):101723. doi: 10.1016/j.jsps.2023.101723. Epub 2023 Jul 31.
8
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.2023年国际血栓与止血学会（ISTH）对2022年COVID-19抗栓治疗ISTH指南的更新。
J Thromb Haemost. 2024 Jun;22(6):1779-1797. doi: 10.1016/j.jtha.2024.02.011. Epub 2024 Mar 18.
9
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients.非危重症住院患者高血糖的药物治疗
Diabetes Spectr. 2014 Aug;27(3):180-8. doi: 10.2337/diaspect.27.3.180.
10
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis.不同抗凝方案对 COVID-19 住院患者死亡率和出血的影响：一项系统评价和更新的荟萃分析。
Semin Thromb Hemost. 2021 Jun;47(4):372-391. doi: 10.1055/s-0041-1726034. Epub 2021 Apr 13.
本文引用的文献
1
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19.COVID-19 住院非危重症患者抗凝策略的随机试验。
J Am Coll Cardiol. 2023 May 9;81(18):1747-1762. doi: 10.1016/j.jacc.2023.02.041. Epub 2023 Mar 6.
2
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies.肝素全剂量抗凝对住院非危重症 COVID-19 患者生存的影响：高质量研究的荟萃分析。
Lung. 2023 Apr;201(2):135-147. doi: 10.1007/s00408-023-00599-6. Epub 2023 Feb 4.
3
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.COVID-19 非危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
Zotero 插件